CAMBRIDGE, England & LONDON--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and ...
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization Broken String Biosciences (“Broken String”), ...
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its ...
Broken String Biosciences, a gene therapy company based in Cambridge, U.K., has announced a new research collaboration with the Francis Crick Institute in London. The Crick Institute’s researchers ...
Broken String Biosciences launched an early access program (EAP) through which select developers of gene edited therapeutics will be able to use Broken String’s INDUCE-seq ® technology in their own ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
- Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity - Peer-reviewed data demonstrates the sensitivity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback